This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Price tag on gene therapy for rare blindness sparks debate
A one time genetic treatment for a rare inherited blindness will cost 850000 per patient, ranking among the world’s most expensive medicines and prompting insurers and policymakers to weigh access against breakthrough science. Spark Therapeutics adjusted Luxturna’s price after concerns about affordability, while insurers consider installment plans and risk-sharing as analysts debate value over long term vision outcomes.
MENTIONED IN THIS ARTICLE
Washington
Spark Therapeutics
Spark
Luxturna
U.S
Europe
uniQure
U S
Biogen
Philadelphia
Institute For Clinical and Economic Review
Steven Pearson
Harvard University
Harvard Pilgrim
New England
Albert Maguire
Misa Kaabali
Children's Hospital of
Misa